Multicenter Study Results on Expanded Indications in Med‐EL Pediatric Cochlear Implant Population
The Laryngoscope · 19.08.2026
DOI: 10.1002/lary.70840 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, online erschienen am 19.08.2026. Verfasst von Nancy M Young und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Otolaryngology-Head and Neck Surgery, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lillian S Wells Foundation, MED-EL Corporation.
Abstract (Originalsprache)
Objectives
To demonstrate safety and efficacy of MED‐EL cochlear implants (CIs) in children aged < 12 months and in children aged 12–71 months with residual hearing.
Methods
This was a multicenter, nonrandomized, single‐subject, repeated‐measures study with prospective ( N = 38; 26 < 12 months of age) and retrospective ( N = 209; 70 < 12 months of age) arms. All subjects received MED‐EL CIs before age 6 and had safety data for analysis. Thirty‐six of 38 prospective and 92 of 209 retrospective subjects had efficacy data available for analysis. Primary efficacy endpoint hypothesized that ≥ 75% of subjects would meet study‐specific performance goals on speech recognition or auditory skill development measures by 12 months post‐activation. Primary safety endpoint was adverse device effects (ADEs).
Results
Twenty‐nine of 36 prospective (80.6%) and 81 of 92 retrospective (88.0%) subjects with 12‐month efficacy data met endpoint performance goals. This included 21 of 25 (84.0%) prospective and 32 of 37 (86.5%) retrospective subjects < 12 months old and 6 of 6 prospective and 30 of 34 (88.2%) retrospective subjects 12–71 months old with residual hearing. Prospective sample size was too small for hypothesis testing, but the retrospective cohort met the primary efficacy endpoint (95% CI: 79.6%, 93.9%; p = 0.002). Nine prospective and 33 retrospective subjects experienced any ADE, including serious ADEs (SADEs) in < 6% of subjects. No unanticipated ADEs.
Conclusion
Results suggest that it is appropriate to expand pediatric CI indications to include children aged 7–11 months with profound sensorineural hearing loss (SNHL) and children aged 12–71 months with residual hearing. Level of Evidence 3
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Otolaryngology-Head and Neck Surgery, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
- Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
- Knowles Hearing Center, Department of Communication Sciences and Disorders, Northwestern University, Evanston, Illinois, USA.
- Department of Audiology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
- Tahoe Forest Health System, Truckee, California, USA.
- Department of Otolaryngology - Head and Neck Surgery, University of Mississippi Medical Center, Jackson, Mississippi, USA.
ORCID-Profile: Nancy M Young, Ivette Cejas, Lisa R Park, Kevin D Brown
Förderung
- Lillian S Wells Foundation
- MED-EL Corporation
Zitieren
APA
Young, N. M., Thomas, D., Hoff, S. R., Carron, J. D., Gonzalez, V. B., Sanchez, C. M., Cejas, I., Bauer, P. W., Gross, A. J., Richter, M. E., Park, L. R., & Brown, K. D. (2026). Multicenter Study Results on Expanded Indications in Med‐EL Pediatric Cochlear Implant Population. The Laryngoscope. https://doi.org/10.1002/lary.70840
Vancouver
Young NM, Thomas D, Hoff SR, Carron JD, Gonzalez VB, Sanchez CM, et al. Multicenter Study Results on Expanded Indications in Med‐EL Pediatric Cochlear Implant Population. The Laryngoscope. 2026. doi:10.1002/lary.70840
BibTeX
@article{Young2026,
author = {Young, Nancy M and Thomas, Denise and Hoff, Stephen R and Carron, Jeffrey D and Gonzalez, Victoria B and Sanchez, Chrisanda M and Cejas, Ivette and Bauer, Paul W and Gross, Aimee J and Richter, Margaret E and Park, Lisa R and Brown, Kevin D},
title = {Multicenter Study Results on Expanded Indications in Med‐EL Pediatric Cochlear Implant Population},
journal = {The Laryngoscope},
year = {2026},
doi = {10.1002/lary.70840}
}
EUVIMED